J. Goldman & CO LP Verrica Pharmaceuticals Inc. Transaction History
J. Goldman & CO LP
- $2.89 Billion
- Q1 2024
A detailed history of J. Goldman & CO LP transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 27,000 shares of VRCA stock, worth $229,770. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,000
Previous 108,000
75.0%
Holding current value
$229,770
Previous $790,000
79.87%
% of portfolio
0.01%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding VRCA
# of Institutions
61Shares Held
16.2MCall Options Held
0Put Options Held
0-
Perceptive Advisors LLC New York, NY7.1MShares$60.4 Million0.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY4MShares$34 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.27MShares$10.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.11MShares$9.48 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA449KShares$3.82 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $350M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...